Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate Acid for Neuroprotection and Epilepsy Prevention in Severe TBI
NCT02027987Phase 1Unknown
- Sponsor
- Xijing Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in traumatic brain injury (TBI) comparing Valproate Acid with Placebo (2 arms). Primary endpoint: Disability Rating Scale scores at 42 days. Status: unknown.
02
Drugs
valproic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02027987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027987.